Clinical Results & Evidence
Comprehensive clinical data from over 35,000 patients demonstrating the safety and effectiveness of Inspire therapy for obstructive sleep apnea.
79%
Reduction in AHI (sleep events per hour)
94%
Patient satisfaction rate
90%
Bed partner satisfaction
STAR Trial: 5-Year Outcomes
Study Overview
- 126 patients with moderate to severe OSA who failed CPAP
- Multi-center prospective study across 22 leading medical centers
- FDA approval based on 12-month primary endpoints
- 5-year follow-up data demonstrating sustained effectiveness
AHI Reduction
Median AHI decreased from 29.3 to 6.2 events per hour
79% reduction
ODI Improvement
Oxygen Desaturation Index improved from 25.4 to 7.4 events/hour
71% reduction
Quality of Life Improvements
85%
Reduction in daytime sleepiness (ESS scores)
91%
Reported better quality sleep
90%
Bed partners reported eliminated or soft snoring
88%
Would recommend to friends and family
Real-World Evidence
ADHERE Registry (n=5,000+ patients)
- • Consistent outcomes across diverse patient populations
- • 73% reduction in AHI at 12 months
- • High therapy adherence: Average use 5.6 hours per night
- • Significant improvements in blood pressure control
Post-Market Studies (35,000+ patients)
- • Low serious adverse event rate (<2%)
- • Sustained effectiveness through 5+ years
- • Improved cardiovascular outcomes
- • Reduced healthcare utilization
Safety Profile
Procedure Safety
- Outpatient procedure (most patients go home same day)
- Low complication rate (<2%)
- No facial changes or scarring
Long-Term Safety
- MRI conditional (safe with most MRI scans)
- Battery life 11+ years
- Reversible if needed
Ready to Experience These Results?
Join the thousands of patients who have found freedom from CPAP with clinically-proven Inspire therapy.